Tong et al. [76], observed this pro-apoptotic effect in heterozygous-JAK2 mutant HSCs in individuals with ET treated with IFNα, while cell cycling was only modestly enhanced. The gene discussed is IFNA1; the disease is essential thrombocythemia.